3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Enrolling by invitation
1
Sponsor Class
OTHER
83
INDUSTRY
16
NIH
5
NETWORK
4
OTHER_GOV
2
UNKNOWN
1
Study Type
Observational
2
Sponsor
Cancer Type
Breast
2
Lymphoid
1
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
5
Neoplasms
4
Lung Neoplasms
3
Uterine Cervical Neoplasms
2
Small Cell Lung Carcinoma
2
Rectal Neoplasms
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Breast Neoplasms
2
Unresectable Non-small Cell Lung Cancer
1
Tobacco Use Cessation
1
Recurrence
1
Rectal Diseases
1
Pancreatic Cancer Liver Metastases
1
Ovarian Neoplasms
1
Ototoxicity
1
Neoplasms, Second Primary
1
Neoplasms by Site
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Mouth Neoplasms
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Intestinal Neoplasms
1
Intestinal Diseases
1
Hodgkin Disease
1
Hearing Loss
1
HER2 Positive Metastatic Breast Cancer
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Interventions
Tamoxifen
10
Docetaxel
8
Trastuzumab
7
Paclitaxel
6
Letrozole
6
Gemcitabine
6
Exercise
6
Control Groups
6
exemestane
5
Indocyanine Green
5
Cyclophosphamide
5
Carboplatin
5
Anastrozole
5
pertuzumab
4
dalpiciclib
4
Vinorelbine
4
Doxorubicin
4
Capecitabine
4
pyrotinib
3
Surgical Procedures, Operative
3
Standard of Care
3
Radiotherapy
3
Radiation
3
Mammography
3
Fulvestrant
3
Cisplatin
3
ferumoxides
2
Zoledronic Acid
2
Tablets
2
Surveys and Questionnaires
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Breast Neoplasms
×
Drug Therapy
×
Clear all
NCT04488614
2020-07-30
PBCB
Helse Stavanger HF
Enrolling by invitation
1,200 enrolled
NCT03062072
2017-04-07
ECHO
National Cancer Center, Korea
Unknown
300 enrolled